Applying these signatures to our data, the three TCF7-SPI1 fusion positive cases were positively enriched for an ETP-ALL signature and negatively enriched for the complementary T-ALL signature (Fig. 2h, i, Supplementary Fig. 3a–f). The gene discussed is SPI1; the disease is acute lymphoblastic leukemia.